Thymalin (thymus polypeptide fraction): preparation and storage
Intended for research use only. Not a medicinal product.
Contents (8 sections)
Identity and material form
Tymalin, also called Thymalin, is a preparation of a thymic peptide fraction. It is a mixture rather than one peptide with a universal molecular weight. Distinguish it from thymosin alpha-1, thymosin beta-4 and synthetic Glu-Trp. Even when a short sequence is described as a component or activity model, it does not describe the whole extract batch.
Preparation requires raw-material origin, fraction specification and lyophilisate composition. A filler has its own mass and may affect the medium. A “10 mg” statement without clarification of active fraction versus total powder does not establish an unambiguous reagent concentration.
What the research context means
Khavinson and colleagues reviewed Thymalin use for immunocorrection and molecular aspects of its activity [1]. That review helps with terminology but is not a certificate for a current extract or a validation of stored solution. For a particular experiment, find a primary method that identifies the preparation precisely.
Composition matters especially in immune-cell research. If measuring cytokines or inflammatory signalling, assess endotoxin and other matrix factors as required by the method. A cellular signal without appropriate controls cannot assign an effect to a particular peptide sequence within the mixture.
Solvent and final matrix
For a thymic extract, solvent suitability depends on complete transfer and preservation of the component profile. Water and saline buffer can behave differently. Do not select pH from the calculated isoelectric point of one short sequence: the mixture contains other components.
Investigate turbidity before adding the material to cells. If a filter removes it, starting vial mass no longer guarantees filtrate concentration. Record membrane type, volume and quantitative recovery when filtration is part of the method. Filtering the material also does not establish endotoxin removal.
Laboratory calculation example
If the specification confirms 5.00 mg of peptide fraction, a final 2.50 mL gives 2.00 mg fraction/mL. Transferring 25.0 µL within a final 500 µL gives 0.100 mg/mL. Retain the full description “mg fraction/mL” in the record rather than converting it to the molar concentration of an unspecified peptide.
Matching two batches at the same mg/mL does not establish equal quantities of every component. Between-batch comparisons need an agreed profile or validated marker. This illustrates mass accounting rather than selecting an immunological exposure concentration.
Quality checks during handling
For an immune-cell assay, prepare the filler control at its actual final-well amount. If filler composition is unknown, an exact control cannot be reproduced; state that limitation in the protocol. A solvent blank controls only solvent rather than excipients. For endotoxin-sensitive signals, the corresponding test result also requires confirmation of suitability for the extract matrix.
Compare chromatographic profiles before and after the working interval if this is an accepted quality measure. Loss of one component may leave total mass or total-protein signal unchanged. Retain the method rather than only a chromatogram image: different gradients and detectors can give different relative areas.
If a batch changes during a prolonged experiment, do not silently pool it with the previous one. Record the change date, profile and normalisation basis. Where needed, compare both batches in the same series with a matching cellular matrix before attributing changed signals to biology.
Dry material and solution need separate conditions
Extract storage conditions follow the formulation rather than the general description “peptides”. A dry research form can be stored long term in a freezer only where its specification explicitly supports this; do not freeze a finished product or solution by analogy with synthetic AEDG. A refrigerator at +2–8 °C for a week or a month is suitable only where the manufacturer supports that interval for the relevant form.
Allow a sealed cold vial to reach room temperature before opening where compatible with its instructions, to limit condensation. Record solution date, solvent, concentration and permitted holding time. Aliquoting reduces repeated opening but does not itself establish stability after freezing. Without solution data, plan preparation for the current experiment rather than assigning the dry extract's shelf life.
Practical questions
Is Tymalin thymosin alpha-1? No. An extract and a defined synthetic peptide require different specifications. Can Glu-Trp molecular weight be applied to the whole extract? No: that would produce a false molarity.
Does clarity establish suitability for a cytokine assay? No. Matrix compatibility and relevant microbial-impurity controls are needed. Can reconstituted extract follow dry-form storage? No. Adding liquid introduces a separate solution specification.
Monograph · Product page · Certificates of analysis
General reagent preparation · Bacteriostatic water compatibility · Storage and expiry
Sources
- Khavinson V. Kh., Linkova N. S., Chalisova N. I., Ivko O. M.. The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity. 2021.
End of article
Thymalin
for laboratory research
Packs and current prices on the product page.
